Attached files
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the
SECURITIES EXCHANGE ACT OF 1934
March 16, 2011
Date of Report (Date of Earliest event reported)
GLOBAL NUTECH, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada 333-149857 26-0338889
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
5412 Bolsa Avenue, Suite D, Huntington Beach, CA 92649
(Address of principal executive offices) (Zip code)
(714) 373-1930
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13c-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 7 - REGULATION FD
ITEM 7.01. REGULATION FD DISCLOSURE.
On March 16, 2011, the Company issued a Press Release concerning the action of
its Joint Venture entity, Enzyme Bio-Sciences LLC initiating an advertising
campaign in American Dog Magazine. A copy of the Press Release is attached
hereto as Exhibit 99.1 and the information therein is incorporated herein by
reference.
The information in this Form 8-K and the Exhibit attached hereto shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, regardless of any
general incorporation language in such filing.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit No. Description
----------- -----------
99.1 Press Release dated March 16, 2011
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: March 16, 2011 GLOBAL NUTECH, INC.
By: /s/ E. G. Marchi
------------------------------------
Name: E. G. Marchi
Title: President